|

Automated Insulin for Management of Intrapartum Glycemia

RECRUITINGN/ASponsored by University of California, San Francisco
Actively Recruiting
PhaseN/A
SponsorUniversity of California, San Francisco
Started2025-12-05
Est. completion2026-12-31
Eligibility
Age18 Years – 55 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.

Eligibility

Age: 18 Years – 55 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Currently pregnant at ≥ 34 weeks
* Known diagnosis of type 1 diabetes ≥ 1 year
* Use of commercially available AID system since at least 28 weeks gestation
* Singleton pregnancy
* English- or Spanish-speaking

Exclusion Criteria:

* Multifetal gestation
* Planned cesarean delivery
* Use of medications known to interfere with glucose metabolism
* Intrauterine fetal demise
* Physical or psychological disease likely to interfere with the conduct of the study and/or the ability to participate in own healthcare

Conditions4

DiabetesPre-Gestational DiabetesPregnancyType 1 Diabetes (T1D)

Locations1 site

University of California, San Francisco
San Francisco, California, 94143
Nasim Sobhani415-307-9319dappresearch@ucsf.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.